Skip to content

A study to evaluate the effectiveness of personalized homoeopathic treatment in patients with allergic rhinitis (nasal allergy)

A prospective interventional study on the therapeutic value of individualized homoeopathic medicine through complete repertory in the treatment of allergic rhinitis - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109549
Enrollment
50
Registered
2026-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicine: Individualized homoeopathic medicine after repertorisation from complete repertory with homoeopathic posology. Control Intervention1: NIL: NIL

Sponsors

R.B.T.S. Government Homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients diagnosed with allergic rhinitis based on clinical signs and symptoms such as sneezing, nasal congestion, watery nasal discharge, itching of nose, eyes, throat. 2 Age group: Patients aged 12 to 60 years, irrespective of gender. 3 Patients willing to undergo individualized homeopathic treatment and follow up regularly for the study duration. 4 Cases with clear individualizing symptoms suitable for prescription through Complete Repertory. 5 Patients not on any long-term antihistamines, corticosteroids, or other immunosuppressive therapy (or willing to discontinue under supervision prior to study entry).

Exclusion criteria

Exclusion criteria: 1 Patients with structural nasal abnormalities (deviated nasal septum, nasal polyps) contributing to symptoms. 2 Patients with chronic sinusitis, asthma, or other major respiratory or systemic diseases that may interfere with allergic rhinitis evaluation. 3 Patients on long-term allopathic treatment such as corticosteroids, immunotherapy, or antihistamines unwilling to discontinue or taper off under medical supervision. 4 Pregnant and lactating women, due to hormonal influence on immune response and limitations in prescribing. 5 Patients with psychiatric illness or cognitive impairment affecting communication or compliance with treatment and follow-up. 6 Patients already under any other form of alternative therapy (like Ayurveda, Unani.) for allergic rhinitis during the study period. 7 Patients unwilling or unable to provide informed consent or commit to regular follow-up.

Design outcomes

Primary

MeasureTime frame
Change (reduction) in Total Nasal Symptom Score (TNSS) from baseline to 3 months after individualized homoeopathic treatment in patients with allergic rhinitis.Timepoint: 3 months- 4 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Divya Kumari

R.B.T.S. Government Homoeopathic medical college and hospital

drramkumar26@gmail.com9470039820

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026